Scientific article supports AEterna Zentaris' development of perifosine inhibitor

Full story: Medical News

AEterna Zentaris Inc. , a global biopharmaceutical company focused on endocrine therapy and oncology, today announced publication of a scientific article in the renowned Journal of Urology, supporting the development of the Company's PI3K/Akt pathway inhibitor oral compound, perifosine, for the treatment of cancer.

Leave a Comment

Comments

Type in your comments to post to the forum

Name
(appears on your post)

Comments

Type the numbers you see in the image on the right:

Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Other Recent Urology Discussions

Topic	Updated	Last By	Comments
post ejaculation, I pee, then I just FEEL like ... (Sep '06)	39 min	Max Payne	372
Gene For Devastating Kidney Disease Discovered	Tue	Stephany McD...	1
Burning Head of Penis , Sore Testicles, And Pai... (Jun '07)	Dec 20	scientist	105
Lots of sex could prevent erectile dysfunction (Jul '08)	Dec 18	Andre	7
New treatment for Erectile Dysfunction	Dec 17	firefox	2
Erectile Dysfunction May Be Sign Of Other Trouble (Nov '07)	Dec 17	Swiss Tony	8
Erectile Dysfunction May Be Sign Of Other Trouble (Nov '07)	Dec 17	Timeseeker50	4